Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results
Continued enrollment in Phase 2 clinical trial of AT-1501 in amyotrophic lateral sclerosis (ALS) First patient to be enrolled in Phase 2 clinical trial of AT-1501 in islet cell transplantation for type 1 diabetes expected in Q2’21 Cash Balance of $114.2 …